Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
SGO 2022 on Clinical Outcomes of Ovarian Cancer Patients Treated With the Novel Engineered Cytokine Nemvaleukin Alfa + Pembro: Recent Data From ARTISTRY-1
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Ira Winer
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Ira Winer
Login to view comments.
Click here to Login
